Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-06-26
1999-03-23
Knode, Marian C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 50, 536 2854, 530351, A61K 3800, A61K 3170
Patent
active
058859578
ABSTRACT:
Treatment of animals or humans carrying or infected with HTLV-I, HTLV-I (including HTLV-I-associated leukemias or lymphomas), non-A, non-B hepatitis virus, hepatitis B virus, EBV, equine infectious anaemia or other lentiviruses or having antibodies to said viruses is disclosed using the compound 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof.
Also disclosed is the use of the 5'-mono-, di- and triphosphate of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof for the same purpose.
REFERENCES:
patent: 3660564 (1972-05-01), Yoneda et al.
patent: 4360522 (1982-11-01), Schaeffer
patent: 4649140 (1987-03-01), Schaeffer
patent: 4695570 (1987-09-01), Krenitsky
patent: 4723232 (1988-02-01), Rideout et al.
patent: 4874609 (1989-10-01), Rideout et al.
patent: 5521161 (1996-05-01), Malley et al.
patent: 5643891 (1997-07-01), Rideout et al.
C.J. Krieg, et al., "Increase in Intracisternal A-Type Particles in Friend Cells During Inhibition of Friend Virus (SFFV) Release by Interferon or Azidothymidine," Experimental Cell Research 116, (1978) pp. 21-29.
W. Ostertag, et al., "Induction of Intracisternal A-Type Particles During Friend Cell Differentiation," Experimental Cell Research 116, (1978) pp. 31-37.
Donald E. Riesenberg, MD, "Anti-AIDS agents show varying early results in vitro and in vivo," JAMA(Medical News) Nov. 8, 1995-vol. 254, No. 18, pp. 2521, 2527 & 2529.
M. Anwar Waqar, et al., "Effect of 2',3'-Dideoxynucleosides on Mammalian Cells and Viruses," Journal of Cellular Physiology 121:402-408, 1984.
Ronald P. Glinski, et al., "Nucleotide Synthesis. IV..sup.1 Phosphorylated 3'-Amino-3'-deoxythymidine and 5'-Amino-5'-deoxythymidine and Derivatives.sup.2.3," J. Org. Chem., vol. 38, No. 25, 1975, pp. 4299-4305.
Ruth M. Ruprecht, et al., "Suppression of mouse viraemia and retroviral disease by 3'-azido-3'-deoxythymidine," Nature, vol. 323, Oct. 2, 1986, pp. 467-469.
Hiroaki Mitsuya, "3'-Azido-3'-deoxythymidine (BW A509U):An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro," Proc. Natl. Acad. Sci USA, vol. 82, pp. 7096-7100, Oct. 1985.
Parkash S. Gill, M.D., et al., "Treatment of Adult T-Cell Leukemia-Lymphoma With a Combination of Interferon Alfa and Zidovudine," The New England Journal of Medicine, pp. 1744-1748, Jun. 29, 1995, vol. 332, No. 26.
Olivier Hermine, M.D., et al, Brief Report: Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa, The New England Journal of Medicine, vol. 332, No. 26, pp. 1749-1751, Jun. 29, 1995.
Lin et al., "Synthesis and Biological Activity of Various 3'-Azido and 3'-Amino Analogues of 5-Substituted Pyrimidine Deoxyribonucleosides," J. Medicinal Chem., 26(12), 1691-1696 (Dec. 1983).
Ostertag et al., "Induction of Endogenous Virus and of Thymidine Kinase by Bromodeoxyuridine Cell Cultures Transformed by Friend Virus," Proc. Nat. Acad. Sci. USA, 71(12), 4980-4985 (Dec. 1974).
Horwitz et al., "Nucleosides. V. The Monomesylates of 1-(2'-Deoxy-.beta.-D-lyxofuranosyl)thymine," J. Organic Chem. 29, 2076-20-78 (Jul. 1964).
Vila et al., "Absence of Viral Rebound After Treatment of HIV-Infected Patients with Didanosine and Hydroxycarbamide," The Lancet, 350, 635-636 (Aug. 30, 1997).
Barry David Walter
Furman Phillip Allen
Lehrman Sandra Nusinoff
Rideout Janet Litster
St. Clair Martha Heider
Crane L. Eric
Glaxo Wellcome Inc.
Knode Marian C.
Prus Karen L.
LandOfFree
Treatment of HTLV-I infections does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of HTLV-I infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of HTLV-I infections will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2125448